Coya Therapeutics, Inc.COYANASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank20
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-254.71%
↓ 78% vs avg
Percentile
P20
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
-143.46%
Historical baseline
PeriodValueYoY Change
TTM-254.71%+47.4%
2024-483.88%-296.1%
2023-122.17%-
20220.00%-
20210.00%-
20200.00%-